menu
    • menu

    Company profile for Arrivent

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We have established a deep, global network of biotechs and big Pharmas, providing us with access to unique and best-in-class drug candidates at various development stages, including those coming from the booming life sciences industry in China and other emerging biotech hubs. Through strategic collaborations with innovative biopharma companies, we aim to globalize medicines for patients with a broad range of diseases, with an ...
    We have established a deep, global network of biotechs and big Pharmas, providing us with access to unique and best-in-class drug candidates at various development stages, including those coming from the booming life sciences industry in China and other emerging biotech hubs. Through strategic collaborations with innovative biopharma companies, we aim to globalize medicines for patients with a broad range of diseases, with an initial focus in oncology. When identifying potential candidates, our focus is on compounds that have been validated through rigorous discovery and development processes, potentially mitigating risk

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ArriventUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Pennsylvania Furnace, Pennsylvania
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://arrivent.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/arrivent/about/?viewAsMember=true
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arrivent To Showcase Firmonertinib & ARR-002 At 2026 AACR Meeting
    Arrivent To Showcase Firmonertinib & ARR-002 At 2026 AACR Meeting

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257720/0/en/ArriVent-to-Present-Two-Preclinical-Posters-on-the-EGFR-Inhibitor-Firmonertinib-and-on-the-Novel-dual-target-MUC16-NaPi2b-Tetravalent-ADC-ARR-002-at-the-2026-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Arrivent Biopharma Reports Full Year 2025 Financial Results
    Arrivent Biopharma Reports Full Year 2025 Financial Results

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250640/0/en/ArriVent-BioPharma-Reports-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Arrivent Biopharma Reports Third Quarter 2025 Financial Results
    Arrivent Biopharma Reports Third Quarter 2025 Financial Results

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184528/0/en/ArriVent-BioPharma-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Arrivent Appoints Brent S. Rice As Chief Commercial Officer
    Arrivent Appoints Brent S. Rice As Chief Commercial Officer

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3154297/0/en/ArriVent-Appoints-Brent-S-Rice-as-Chief-Commercial-Officer.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    Arrivent Releases Final Firmonertinib Data in EGFR PACC Cancer
    Arrivent Releases Final Firmonertinib Data in EGFR PACC Cancer

    09 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/09/3146827/0/en/Arrivent-Presents-the-Final-Analysis-of-Firmonertinib-Monotherapy-Data-from-Global-Phase-1b-Study-in-EGFR-PACC-Mutant-Non-Small-Cell-Lung-Cancer-at-the-2025-World-Conference-on-Lun.html

    GLOBENEWSWIRE
    09 Sep 2025
    Share Share
    ArriVent BioPharma Announces Q2 2025 Financial Results
    ArriVent BioPharma Announces Q2 2025 Financial Results

    11 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/11/3130840/0/en/ArriVent-BioPharma-Reports-Second-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    11 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search